| Autor: |
de Souza TF; ABC Medical School, Santo André, Brazil., Madruga Neto AC; Gastrointestinal Endoscopy Unit, Hospital das Clínicas, University of São Paulo Medical School, São Paulo, Brazil., Coronel MA; Gastrointestinal Endoscopy Unit, Hospital das Clínicas, University of São Paulo Medical School, São Paulo, Brazil., Grecco E; ABC Medical School, Santo André, Brazil., Quadros LG; ABC Medical School, Santo André, Brazil., Silva M; Gastroenterology Department, Centro Hospitalar de São João, Porto Medical School - Porto, 4200-319, Porto, Portugal. marcocostasilva87@gmail.com., Abu Dayyeh BK; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA., Dos Passos Galvão Neto M; ABC Medical School, Santo André, Brazil. |
| Abstrakt: |
The authors evaluated, retrospectively, the endoscopic sleeve gastroplasty impact in seven HIV patients, regarding effectiveness and safety outcomes. The mean baseline body mass index (BMI) was 33.76 kg/m 2 . The mean baseline CD4+ cell count was 690.43 cells/mm 3 , and the baseline viral load was undetectable. After 6 months, absolute weight loss, percentage of excess weight loss, percentage total weight loss, and BMI reduction were 20.2 ± 2.6 kg, 85.5 ± 11.1%, 21.3 ± 2.4%, and 7.1 ± 0.8 kg/m 2 , respectively. No patients presented severe adverse events. After 6 months, the viral load remained undetectable and the mean CD4+ cell count was 710.57 cells/mm 3 . The endoscopic sleeve gastroplasty is an effective and safe procedure to perform in obese HIV patients. |
Full text from SpringerLink